Watch Now
Webinar

Pediatric Cancer: How Genomics Impact Treatment and Clinical Trials

  • Fiona Evans
    Lead Patient Advocate

Pediatric Cancer: How Genomics Impact Treatment and Clinical Trials aired live on Facebook featuring two pediatric oncologists Jason Freedman and Ted Laetsch. This event was hosted by Fiona Evans, Lead Patient Advocate at Massive Bio. During this event on the Massive Bio Facebook page, attendees heard from and asked questions to two pediatric oncologists. Fill out the form on this page to watch the full event. Topics that were covered during the event include:

  • Importance of biomarkers in cancer treatment
  • Common biomarkers in pediatric cancer
  • How to get genomic testing
  • Importance of clinical trials
  • What therapies are used to target these biomarkers?

Clinical trials test the latest scientific advancements in childhood cancer treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. Childhood cancer patients might gain access to promising drugs and innovative treatments long before they’re made available to the public. During the event, we will also take questions directly from the community on topics such as pediatric cancer clinical trials, genomic testing, and biomarkers in cancer. At the end of the event, the live Q&A will answer all submissions.

With Massive Bio’s AI technology, finding a clinical trial doesn’t have to be difficult or time consuming for patients or their physicians. Let us help you and your patients find the best trial within 48 hours of receipt of records. Pediatric Cancer: How Genomics Impact Treatment and Clinical Trials aired on Monday, November 22nd at 5:00pm EST. Fill out the form to register for the event. Watch the full event to learn about pediatric cancer clinical trials, how Massive Bio can help pediatric patients, and more!

Join our community
and receive our newsletter